T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
35 hedge funds and large institutions have $78.3M invested in T2 Biosystems, Inc in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
407% more call options, than puts
Call options by funds: $289K | Put options by funds: $57K
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
3% less funds holding
Funds holding: 36 → 35 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
13% less capital invested
Capital invested by funds: $90.4M → $78.3M (-$12.1M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
+$1.34M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$970K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$351K |
| 4 |
BRC
Bell Rock Capital
Rehoboth Beach,
Delaware
|
+$268K |
| 5 |
Morgan Stanley
New York
|
+$268K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$8.19M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.33M |
| 3 |
LIM
Lagoda Investment Management
New York
|
-$1.94M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$516K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$420K |
TTOO Hedge Fund Activity: Q4 2017 in Review
35 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2017, worth a combined $78.3M — down 13% from $90.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of TTOO and 7 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 8 added.
The largest buyer was Tiger Management, adding an estimated $1.34M. The largest seller was Flagship Pioneering, exiting entirely with an estimated $8.19M sold.
- 35 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2017, down from 36 in Q3 2017.
- Funds reported $78.3M of T2 Biosystems, Inc stock for Q4 2017, down 13% quarter-over-quarter.
- 7 funds opened new T2 Biosystems, Inc positions in Q4 2017 and 8 closed out, a net change of -1 holder.
- The largest T2 Biosystems, Inc buyer in Q4 2017 was Tiger Management, an estimated $1.34M added.
- The largest T2 Biosystems, Inc seller in Q4 2017 was Flagship Pioneering, an estimated $8.19M sold.
Based on aggregated 13F filings for Q4 2017.